Earlier this week, Herbalife reported quarterly revenue growth of 6.3% year on year, beating analyst expectations and surpassing its own guidance for net sales and adjusted EBITDA, alongside highlighting Cristiano Ronaldo’s backing of personalized nutrition platform Pro2col. In India, Herbalife also released a new episode of its “Live Your Best Life, Unscripted” podcast featuring social entrepreneur Ruma Devi, underscoring the brand’s emphasis on empowerment, community impact, and its push into more personalized wellness offerings. We’ll now examine how Herbalife’s better-than-expected earnings and personalized nutrition initiatives may influence its longer-term investment narrative.
Capitalize on the AI infrastructure supercycle with our selection of the 35 best ‘picks and shovels’ of the AI gold rush converting record-breaking demand into massive cash flow.
Herbalife Investment Narrative Recap
To own Herbalife, you need to believe its shift toward personalized, data-driven wellness can strengthen revenue and distributor engagement despite high leverage and past earnings pressure. The latest quarter’s 6.3% revenue growth and guidance beat support that narrative, but the stock’s 4.3% drop after earnings highlights that balance sheet risk and questions about the durability of demand remain the key near term swing factors.
The most relevant update here is Herbalife’s better than expected net sales and adjusted EBITDA, which sit alongside Cristiano Ronaldo’s backing of the Pro2col personalized nutrition platform. Together, they reinforce the idea that digital tools and tailored nutrition could be a growth catalyst, even as the company continues to manage refinancing plans for its sizeable secured debt and contends with softer net income trends.
Yet despite the upbeat headlines, investors should still be aware of…
Read the full narrative on Herbalife (it’s free!)
Herbalife’s narrative projects $5.6 billion revenue and $152.6 million earnings by 2028. This implies 4.4% yearly revenue growth and an earnings decrease of $172.4 million from $325.0 million today.
Uncover how Herbalife’s forecasts yield a $14.00 fair value, a 6% downside to its current price.
Exploring Other Perspectives
HLF 1-Year Stock Price Chart
Some of the lowest ranked analysts were assuming revenue of about US$5.7 billion and earnings near US$175.8 million by 2028, which is far more cautious than narratives focused on digital growth and personalized nutrition, so you should weigh this pessimistic view against the latest results and decide how much conviction you really have.
Explore 8 other fair value estimates on Herbalife – why the stock might be worth over 2x more than the current price!
Form Your Own Verdict
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Ready For A Different Approach?
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it.
Discover if Herbalife might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
